Loading ...There are more and more studies coming out from “honorary” sources that have done “scientific studies” that have concluded that vitamins are baaaaad. WRONG! Nutrition is needed to sustain life, so why are vitamins all of a sudden sooo bad? It’s called corporate corruption, greed, and politics. OH and a bit of “I’ll help you out if you help me out!” On the other side of the story, Orthomolecular science has shown fantastic results from their nutritional studies. Visit www.orthomolecular.org to see for yourself and be briefed on the truth behind some of the quackery that is going on. And now, on with the topic.
The full story * SOURCE - OrthoMolecular.com
Vitamin supplements compete with FDA-sponsored drugs. FDA has been trying to eliminate availability of vitamin supplements for over 45 years. As early as 1962, writes constitutional attorney Jonathan W. Emord, “FDA perceived a competitive threat emerging to drug regulation from the sale of dietary ingredients at above RDA doses.” In 1966, “FDA published a rule that any dietary supplement exceeding 150% of the RDA for a vitamin or mineral would automatically be regulated as a drug.” In 1976, after a “public outcry,” the Proxmire Amendment prohibited FDA from deeming a vitamin or mineral a drug solely because of potency. “Undaunted,” continues Emord, “FDA tried yet again to rid the market of vitamins in the 1970s by claiming on a case by case basis that they were adulterated based on their potency.” FDA also tried to have supplements declared to be unapproved food additives. “FDA’s position was a logical absurdity: Single ingredient dietary supplements were food additives because the ingredients were added to a gelatin capsule which was, FDA said with a wink and a smirk, a food. . . The United States Court of Appeals for the Seventh Circuit described FDA’s position as an “Alice in Wonderland” approach.” In 1980, FDA tried to get vitamins classified as over-the-counter drugs. . . FDA has repeatedly exceeded the limits of its statutory authority to bring about changes designed to protect drug companies from competition.”